Beizray
The first and only FDA approved docetaxel injection to be mixed with albumin before administration
What is Beizray?
Beizray is a prescription anticancer medication that includes docetaxel and albumin in a kit containing separate vials of each.
The active ingredient of Beizray, docetaxel, is a chemotherapy that kills cancer cells by interfering with the way they grow. Albumin is a stabilizer, which is used to deliver the docetaxel into your body.
Beizray can cause serious side effects. See the Important Safety Information below and Patient Information. See accompanying full Prescribing Information, including Boxed WARNING.
Take a natural route to docetaxel therapy
Free of synthetic solvents like polysorbate 80 (PS-80) or PEG300.
Hypersensitivity reactions and injection related adverse events can occur from docetaxel itself and may potentially be exacerbated by synthetic solvents, such as PS-80, impacting treatment consistency.*
Instead, Beizray uses human-derived albumin, the body’s most abundant carrier protein, to deliver docetaxel.
*Beizray contains a Boxed WARNING for hypersensitivity reactions, and there is insufficient data demonstrating the incidence or severity of these will be lower with Beizray than with other docetaxel formulations.
Download Patient
Information Sheet
With you at every step
We understand navigating healthcare reimbursement can be challenging. Because of that, our reimbursement experts are available from 8am-8pm ET to answer questions regarding coverage, prior authorization, appeals, co-pay support, and more to help patients start and stay on their medicines – regardless of insurance type.
Download Patient
Assistance Brochure
